Cells were serum-starved for 2 hours at 37°C in DMEM/0.5% BSA and stained with unlabeled mAbs detecting either murine β1 integrin (BD Biosciences, clone 9EG7) or human β1 integrin (Abcam, clone 12G10) at 5 μg/ml in DMEM/0.5% BSA on ice for 30 min (surface binding). Cells were transferred to 37°C for 1 hour to allow internalization (pulse). After pulse, cells were briefly acid-rinsed in 0.5% acetic acid and 0.5 M NaCl (pH 3.0) for 45 s to remove noninternalized and surface-bound antibodies. Cells for pulse-only conditions were either fixed (surface β1 integrin) or fixed and permeabilized (internalized β1 integrin). Cells undergoing chase were chased in antibody-free complete medium for 2 or 4 hours at 37°C to assess receptor recycling back to the surface (Chase/2h or Chase/4h), and cells were fixed or fixed/permeabilized. The remaining β1 integrin mAbs in pulse-only and pulse/chase conditions were detected by with an FITC-labeled secondary antibody and measured by IF or flow cytometry. Cells were exposed to 25 μM of the myristoylated ARF6 2-13 peptide or vehicle before assay.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.